Surging demand for radiation therapy in the backdrop of rising morbidities due to cancers as compared to other chronic diseases altogether in developed and under-developed economies are surfacing as the cornerstone for the progress of absorbable tissue spacer market, says the FMI study. Furthermore, stringent legal policies will persist to regulate the emission of high-energy rays during radiotherapy treatment and assure patient safety, which is likely to motivate manufacturers to perform clinical studies by consulting with experts.
Increasing prevalence of cancers continues to be a global concern, and elimination of cancerous tissues in an efficient way remains of core interest for oncologists and dosimetrists. The leading participants in absorbable tissue spacers market landscape are focusing on conducting clinical trials to develop spacers that are tailored to specific needs of the target area.
Hydrogel-based Spacer Remains Preferred among Surgeons
As per the findings of FMI’s research, hydrogel-based absorbable tissue spacers account for ~3/4th shares of total sales. The report further suggests that the hydrogel-based spacer is rapidly becoming an integral component of prostate cancer radiotherapy and is one of the few absorbable tissue spacers that have received government clearance in most of the countries.
Hydrogel-based spacers have high tolerability as the space created between prostate and rectum efficiently lowers the emission concentration on the rectum, significantly reducing irritation of rectum during prostate radiotherapy. Placing hydrogel-based spacers is technically less-complicated, especially for surgeons who are aware of ultrasound-directed transperineal injections. Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scans enable confirmation about proper deployment of spacers. Furthermore, patients undergoing radiation therapy with hydrogel-based spacers are lesser prone to adverse long-term rectal complications and relatively decreased amount of rectal pain during treatment, making hydrogel-based spacer most sought-after among oncologists.
Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-8507
Cancer specialists are constantly shifting towards absorbable tissue spacer to cure different types of cancers. Absorbable tissue spacers, after proper placement, protects the adjacent healthy tissues from strong radiation, resulting in increased concentration of dose delivery at the affected organ, thereby eliminating adverse procedural events. Further, absorbable tissue spacers avoid the need for a second surgery for spacer removal as they gradually dissolve into the tissues.
The market for absorbable tissue spacer is still young, and this study tracks the growth of absorbable tissue spacers market over the period of next decade. The study unfolds how increasing investments of stakeholders in clinical trials of newly innovated absorbable tissue spacers will contribute towards the progress of the market. Although Europe was the only region driving the growth of absorbable tissue spacers market till a couple of years ago, FMI attempts to analyze how the penetration will increase in other regional markets over the course of next decade.
Increasing Investments and R&D
The absorbable tissue spacer market is extremely compact with four players operating the market. Ongoing clinical studies in various regions for diverse applications of absorbable tissue spacers. Investments and funding for the manufacturers working in the absorbable tissue spacer market is also on the rise.
Government support on investments related to capital costs in order to improve the healthcare infrastructure in various regions is one of the factors that is expected to spur the market for absorbable tissue spacer during the forecast period.
Funding for the manufacturers functioning in the absorbable tissue spacer market and acquisitions, mergers, licensing agreements and distribution are also expected to drive the market and further boost the demand for absorbable tissue spacer during the forecast period.
By Product Type
- Hydrogel-Based Spacer
- Biodegradable Hyaluronic Acid Spacer
- Biodegradable Balloon Spacer
- Crystal-Based Spacer
- Infection Management
By End Use
- Ambulatory Surgical Centres
- Specialized Clinics
- North America
- Latin America
- South Asia
- East Asia
Buy Complete Report @ https://www.futuremarketinsights.com/checkout/8507
Future Market Insights
Unit No: AU-01-H Gold Tower (AU), Plot No: JLT-PH1-I3A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: email@example.com
For Media Enquiries: firstname.lastname@example.org